Correlation Between Cantargia and Vicore Pharma

Can any of the company-specific risk be diversified away by investing in both Cantargia and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cantargia and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cantargia AB and Vicore Pharma Holding, you can compare the effects of market volatilities on Cantargia and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cantargia with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cantargia and Vicore Pharma.

Diversification Opportunities for Cantargia and Vicore Pharma

0.41

Correlation Coefficient

Cantargia  Vicore Pharma

Very weak diversification

The 3 months correlation between Cantargia and Vicore is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Cantargia AB and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and Cantargia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cantargia AB are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of Cantargia i.e., Cantargia and Vicore Pharma go up and down completely randomly.

Pair Corralation between Cantargia and Vicore Pharma

Assuming the 90 days trading horizon Cantargia AB is expected to under-perform the Vicore Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Cantargia AB is 1.15 times less risky than Vicore Pharma. The stock trades about -0.17 of its potential returns per unit of risk. The Vicore Pharma Holding is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest  1,620  in Vicore Pharma Holding on September 2, 2024 and sell it today you would lose (836.00) from holding Vicore Pharma Holding or give up 51.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cantargia AB  vs.  Vicore Pharma Holding

Cantargia AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cantargia AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Vicore Pharma Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vicore Pharma Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Cantargia and Vicore Pharma

The main advantage of trading using opposite Cantargia and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cantargia position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.

The idea behind Cantargia AB and Vicore Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.